Effects of aerosolized dexamethasone on acute subglottic injury.
Aerosolized dexamethasone was used in a two-phase study to determine the possible effects on acute subglottic injury in the ferret animal model. In phase 1, equivalent subglottic injuries were made in 10 animals by using the brush technique, and the animals were divided into two groups. The treatment group received aerosolized dexamethasone at 2, 4, and 6 hours postinjury. All animals were examined 2, 4, 6, and 24 hours after the injury. The clinical condition of each animal was evaluated and their airways were measured. The animals were then painlessly killed and the larynges were frozen, sectioned, and photographed at 1-mm intervals. A computer-linked digitizer pad was used to measure the subglottic dimensions. The results show a trend for the treated animals to have a larger subglottic airway as compared to the untreated (control) group. The phase 1 study suggests that there may be an improvement in the subglottic airway when treated acutely with aerosolized dexamethasone. In phase 2, 20 additional animals were studied by using the same methods of injury and treatment as in phase 1. The subglottic airways of these animals were evaluated with histomorphometric analysis on fixed histologic sections. A statistically significant difference was found between the subglottic airways of the treated and untreated animals favoring treatment with aerosolized dexamethasone. Aerosolized dexamethasone appears to be beneficial in preserving the subglottic airway after injury, possibly secondary to decreasing the edema associated with injury.
Kryzer
T C
TC
Department of Surgery, Uniformed Services University of the Health Sciences, Washington, DC.
Gonzalez
C
C
Burgess
L P
LP
D000208:Acute Disease; D000280:Administration, Inhalation; D000818:Animals; D003907:Dexamethasone / Q000008:administration & dosage*; D005289:Ferrets; D005931:Glottis / Q000293:injuries*; D007819:Laryngeal Edema / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D007828:Laryngoscopy; D007830:Larynx / Q000473:pathology
D003907:Dexamethasone